1117-AA61 202210 The Regulatory Plan and the Unified Agenda of Federal Regulatory and Deregulatory Actions 1117 Drug Enforcement Administration DEA 1100 Department of Justice DOJ Electronic Prescriptions for Controlled Substances

By this final rule, the Drug Enforcement Administration (DEA) would finalize its regulations to clarify: (1) the criteria by which DEA-registered practitioners may electronically issue controlled substance prescriptions; and (2) the criteria by which DEA-registered pharmacies may receive and archive these electronic prescriptions. The finalized rule would contain modifications from the interim-final rule previously published. The final regulations would modify the requirements that must be met by any registrant who wishes to dispense controlled substances pursuant to electronic prescriptions, including requirements pertaining to authorized software applications. (The final rule would maintain the discretionary usage of electronic prescriptions found in the interim final rule.)

]]> Other Significant Previously Published in The Unified Agenda Final Rule Stage No No 21 CFR 1300 21 CFR 1304 21 CFR 1306 21 CFR 1311 21 U.S.C. 802 21 U.S.C. 821 21 U.S.C. 827 21 U.S.C. 829 21 U.S.C. 871(b) No ANPRM 03/05/2001 66 FR 13274 NPRM 06/27/2008 73 FR 36722 NPRM Comment Period End 09/25/2008 Interim Final Rule 03/31/2010 75 FR 16236 Interim Final Rule Comment Period End 06/01/2010 Interim Final Rule Effective 06/01/2010 Interim Final Rule Comment Period Reopened 04/21/2020 85 FR 22018 Interim Final Rule Comment Period End 06/22/2020 85 FR 22018 Final Action 03/00/2023 No Businesses None No DRW@dea.gov www.regulations.gov No No Scott Brinks A. Section Chief, Regulatory Drafting and Support Section, Diversion Control Division 1117 Drug Enforcement Administration DEA 571 362-8209 scott.a.brinks@dea.gov 8701 Morrissette Drive, Springfield VA 22152